230 related articles for article (PubMed ID: 2020715)
1. Treatment with recombinant alpha 2b-interferon of chronic HDV hepatitis in children.
Craxì A; Di Marco V; Volpes R; Marra S; Rizzetto M; Rosina F; Barbera C; Bortolotti F; Crivellaro C; Iannuzzi C
Prog Clin Biol Res; 1991; 364():399-404. PubMed ID: 2020715
[No Abstract] [Full Text] [Related]
2. Alpha interferon therapy of chronic delta hepatitis: a pilot study.
Di Bisceglie AM; Negro F; Smedile A; Bergmann K; Hoofnagle JH
Prog Clin Biol Res; 1991; 364():393-7. PubMed ID: 2020714
[No Abstract] [Full Text] [Related]
3. Alpha 2 recombinant interferon in the treatment of chronic hepatitis delta virus (HDV) hepatitis.
Rosina F; Saracco G; Lattore V; Quartarone V; Rizzetto M; Verme G; Trinchero P; Sansalvadore F; Smedile A
Prog Clin Biol Res; 1987; 234():299-303. PubMed ID: 3628384
[No Abstract] [Full Text] [Related]
4. The natural history of chronic type B hepatitis in southern Italy: effect of HBV replication and of HDV infection.
Craxì A; Di Marco V; Magrin S; Scalisi I; Vassallo R; Vinci M; Genova G; D'Amico G; Maisano S; Politi F
Prog Clin Biol Res; 1987; 234():153-65. PubMed ID: 3628374
[No Abstract] [Full Text] [Related]
5. Natural killer cell function during interferon treatment of delta hepatitis.
Actis GC; Maran E; Saracco G; Rosina F; Baldi M; Brunetto M
Prog Clin Biol Res; 1987; 234():305-8. PubMed ID: 3628385
[No Abstract] [Full Text] [Related]
6. Delta viral replication markers in acute and chronic D infection.
Buti M
Prog Clin Biol Res; 1991; 364():201-5. PubMed ID: 2020696
[No Abstract] [Full Text] [Related]
7. Long term interferon treatment of chronic delta hepatitis: a multicenter Italian study.
Rosina F; Pintus C; Meschievitz C; Rizzetto M
Prog Clin Biol Res; 1991; 364():385-91. PubMed ID: 2020713
[No Abstract] [Full Text] [Related]
8. Therapy of chronic delta hepatitis with alpha- and beta-interferon.
Gaudin JL; Trépo C
Prog Clin Biol Res; 1993; 382():345-52. PubMed ID: 8502701
[No Abstract] [Full Text] [Related]
9. Viral dominance patterns in chronic hepatitis delta determine early response to interferon alpha therapy.
Lutterkort GL; Wranke A; Hengst J; Yurdaydin C; Stift J; Bremer B; Hardtke S; Keskin O; Idilman R; Manns MP; Dienes HP; Falk C; Wedemeyer H; Heidrich B
J Viral Hepat; 2018 Nov; 25(11):1384-1394. PubMed ID: 29888837
[TBL] [Abstract][Full Text] [Related]
10. Genetically engineered molecular probes in the study of the natural history of chronic delta hepatitis.
Monjardino J; Saldanha J; Goldin R; Thomas HC
Prog Clin Biol Res; 1991; 364():197-9. PubMed ID: 2020695
[No Abstract] [Full Text] [Related]
11. Hepatitis D virus (delta agent) superinfection in an endemic area of hepatitis B infection: immunopathologic and serologic findings.
Lee SD; Wang JY; Wu JC; Tsai YT; Lo KJ; Lai KH; Tsay SH; Govindarajan S
Scand J Infect Dis; 1987; 19(2):173-7. PubMed ID: 3616486
[TBL] [Abstract][Full Text] [Related]
12. Role of hepatitis B, C, and D viruses in dual and triple infection: influence of viral genotypes and hepatitis B precore and basal core promoter mutations on viral replicative interference.
Jardi R; Rodriguez F; Buti M; Costa X; Cotrina M; Galimany R; Esteban R; Guardia J
Hepatology; 2001 Aug; 34(2):404-10. PubMed ID: 11481626
[TBL] [Abstract][Full Text] [Related]
13. Long-term interferon-alpha treatment of children with chronic hepatitis delta: a multicentre study.
Di Marco V; Giacchino R; Timitilli A; Bortolotti F; Crivellaro C; Calzia R; Iannuzzi C; Prestileo T; Vajro P; Nebbia G; Stringhi C; Rosina F; Biassoni D; Callea F; Rizzetto M; Craxi A
J Viral Hepat; 1996 May; 3(3):123-8. PubMed ID: 8871870
[TBL] [Abstract][Full Text] [Related]
14. Treatment of chronic delta hepatitis with recombinant human alpha interferon.
Hoofnagle J; Mullen K; Peters M; Avigan M; Park Y; Waggoner J; Gerin J; Hoyer B; Smedile A
Prog Clin Biol Res; 1987; 234():291-8. PubMed ID: 3628383
[No Abstract] [Full Text] [Related]
15. [Incidence of hepatitis D virus infection in chronic hepatitis B virus carriers].
Hacibektaşoğlu A; Barut A; Inal A
Mikrobiyol Bul; 1992 Jul; 26(3):224-32. PubMed ID: 1528142
[TBL] [Abstract][Full Text] [Related]
16. Long-term clinical and virological outcome after liver transplantation for cirrhosis caused by chronic delta hepatitis.
Samuel D; Zignego AL; Reynes M; Feray C; Arulnaden JL; David MF; Gigou M; Bismuth A; Mathieu D; Gentilini P
Hepatology; 1995 Feb; 21(2):333-9. PubMed ID: 7843702
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the histological and serological parameters of patients with hepatitis delta virus in active and inactive hepatitis B virus carriers.
Shaikh S; Ram DB; Tanveer S; Talpur A
J Coll Physicians Surg Pak; 2014 Feb; 24(2):97-100. PubMed ID: 24491002
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of hepatitis delta virus (HDV) replication by lymphoblastoid human alpha interferon.
Thomas HC; Farci P; Shein R; Karayiannis P; Smedile A; Caruso L; Gerin J
Prog Clin Biol Res; 1987; 234():277-90. PubMed ID: 3628382
[TBL] [Abstract][Full Text] [Related]
19. Correlation of serum anti-delta with intrahepatic HBV and HDV antigens in patients with chronic active hepatitis.
Caporaso N; Di Sapio M; Del Vecchio-Blanco C; Coltorti M
Prog Clin Biol Res; 1987; 234():137-44. PubMed ID: 3628372
[No Abstract] [Full Text] [Related]
20. High prevalence of hepatitis delta virus infection detectable by enzyme immunoassay among apparently healthy individuals in Mongolia.
Inoue J; Takahashi M; Nishizawa T; Narantuya L; Sakuma M; Kagawa Y; Shimosegawa T; Okamoto H
J Med Virol; 2005 Jul; 76(3):333-40. PubMed ID: 15902700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
